Serialisation regulations to impact all corners of pharma, says Recipharm
The pharma industry is underprepared for the upcoming global regulations says Recipharm, which has inked three new tech deals as part of its €40m serialisation effort.
The pharma industry is underprepared for the upcoming global regulations says Recipharm, which has inked three new tech deals as part of its €40m serialisation effort.
DIA 2016
According to a recent survey, there are significant advantages to adopting eTMF – although some challenges still remain in the shift towards paperless clinical trials.
Over 100 Colorado jobs could be lost following Pfizer’s decision to exit a former Hospira API plant by 2019.
Researchers have developed a new magnetically controlled drug that can dissolve clots up to 4,000 times more efficiently than ordinary enzyme-based drugs.
After much speculation, inVentiv Health has announced that it has been selected by Pfizer as one of its preferred partners.